Venous thromboembolism caused by testosterone abuse in a young man with previously undiagnosed genetic thrombophilia

1. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008 Mar 6;358(10):1037-52. DOI: 10.1056/NEJMra07275310.1056/NEJMra072753Search in Google Scholar

2. National Clinical Guideline Centre (UK). Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing [Internet]. London: Royal College of Physicians (UK); 2012 Jun. http://www.ncbi.nlm.nih.gov/books/NBK132796/Search in Google Scholar

3. Dickerman RD, McConathy WJ, Schaller F, Zachariah NY. Cardiovascular complications and anabolic steroids. Eur Heart J. 1996 Dec;17(12):1912.10.1093/oxfordjournals.eurheartj.a014812Search in Google Scholar

4. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, et al.; FITENAT Study Group. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. DOI: 10.1097/ MBC.0b013e32832f5d7a10.1097/MBC.0b013e32832f5d7aSearch in Google Scholar

5. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters, Thrombosis Research, 1993 April;70(2):123-25. DOI: 10.1016/0049-3848(93)90153-F10.1016/0049-3848(93)90153-FSearch in Google Scholar

6. Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, et al. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis. Acta Biochim Pol. 2008;55(3):587-94. Epub 2008 Sep 18.10.18388/abp.2008_3065Search in Google Scholar

7. Quéré I, Chassé JF, Dupuy E, Bellet E, Molho-Sabatier P, Tobelem G, et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine. Rev Med Interne. 1998 Jan;19(1):29-33. DOI: 10.1016/S0248-8663(97)83696-X10.1016/S0248-8663(97)83696-XSearch in Google Scholar

8. Simone B, Stefano VD, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013 Aug 1;28(8):621-47. DOI: 10.1007/s10654-013-9825-810.1007/s10654-013-9825-8Search in Google Scholar

9. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013 Feb;15(2):153-6. DOI: 10.1038/gim.2012.16510.1038/gim.2012.165Search in Google Scholar

10. De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013 Oct;110(4):697-705. DOI: 10.1160/TH13-01-001110.1160/TH13-01-0011Search in Google Scholar

11. Ilhan E, Demirci D, Güvenç TS, Calık AN. Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids. Turk Kardiyol Dern Ars. 2010 Jun;38(4):275-8.Search in Google Scholar

12. Choi BG, McLaughlin MA. Why men’s hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am. 2007 Jun;36(2):365-77. DOI: 10.1016/j.ecl.2007.03.01110.1016/j.ecl.2007.03.011Search in Google Scholar

13. Glueck CJ, Goldenberg N, Budhani S, Lotner D, Abuchaibe C, Gowda M.et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res. 2011 Oct;158(4):225-34. DOI: 10.1016/j.trsl.2011.06.00310.1016/j.trsl.2011.06.003Search in Google Scholar

14. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Labitue F, Riaz MK, et al. Testosterone, ThrombophilSearch in Google Scholar

• Effects of nitroglycerin combined with continuous regional arterial infusion on severe acute pancreatitis, triglyceride, inflammatory factors and prognosis

• MMP-2 and MMP-9 gene polymorphisms and risk of head and neck carcinomas

• Proposal of a prediction model for prognosis of patients with acute myocardial infarction after percutaneous coronary intervention based on galectin-3 and soluble growth stimulating expressed gene 2 levels

• Crinum latifolium extract inhibits lipopolysaccharide-induced inflammation in human macrophages

• Approaching Risk Management in Medical Laboratories

• Non-inhibitory effects of the potent antioxidant C-phycocyanin from Plectonema sp. on the in vitro glycation reaction

• Associations of serum expressions of miR-499 and sex determining region Y-box 6 with prognosis of acute myocardial infarction patients

• Matrix-assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry (MALDI-TOF MS) for subgingival bacteriome identification in a group of treated periodontitis patients: a case series

• Clinical significance of serum HMGB1 in COPD and correlation with severity of airflow restriction and immune function

• Snapshot of resistance and virulence features in ESCAPE strains frequently isolated from surgical wound infections in a Romanian hospital